Onechain Immunotherapeutics S.l.

Onechain Immunotherapeutics S.l. is an SME in Barcelona, Spain that has taken part in 7 EU-funded projects since 2023, receiving €1.8M in EU funding and leading 1 as coordinator.

EU funding received€1.8M
EU projects7
As coordinator1
Running now5
First EU project2023
Latest project2025
CountrySpain
EU registration (PIC)889572742
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Onechain Immunotherapeutics S.l.'s own share of each project, not the project's full budget.

  • Horizon Europe€1.8M · 7 projects

Projects

7 EU-funded projects, newest first. Onechain Immunotherapeutics S.l. led 1 of them as coordinator. Each links to the official record.

  • ACHILLESPartner

    Advancing in the CHallenge of Improving Lymphoma and LEukemia Survival

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €282ktheir share
  • CARLYAssociated partner

    Development and characterization of a novel CAR T-cell therapy for NHL

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

  • CarrerasPathfindersAssociated partner

    Enabling the next generation in search of blood cancer cures

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • IMMERGEAssociated partner

    Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • ALERTAssociated partner

    Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

  • CARxALLCoordinator

    Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-cell acute lymphoblastic leukemia

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €1.5Mtheir share
  • CarrerasLeadersAssociated partner

    Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cell signaling
  • drug discovery
  • gene therapy
  • hematology
  • immunology
  • immunotherapy
  • leukemia
  • mutation
  • oncology
  • planets
  • proteins
  • stem cells
  • transplantation

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime